You are here

Amgen

Novartis touts effectiveness, safety of autoimmune drug copies

Yahoo/Reuters

Fri, 06/15/18 - 09:57 am

autoimmune disease

Could an old Amgen-developed RA drug make CAR-T treatments safer?

Fierce Biotech

Thu, 06/7/18 - 10:08 am

cytokine release syndrome

Migraine Breakthrough: Not So Fast

Forbes

Wed, 06/6/18 - 09:49 pm

monoclonal antibodies

Amgen's $3.9B Neulasta to face U.S. biosim 'in the coming weeks' with Mylan approval

Fierce Pharma

Tue, 06/5/18 - 12:02 pm

Amgen to ramp up early-stage immuno-oncology with 2 MD Anderson deals

Fierce Biotech

Sat, 06/2/18 - 02:33 pm

MD Anderson Cancer Center

drug development

Small-Cell Lung Cancer

FDA stalls yet another Herceptin copycat, issuing response letter to Amgen/Allergan

Endpoints

Fri, 06/1/18 - 10:40 pm

complete response letter

ASCO Preview: Are Combo Treatments With Cancer-Killing Viruses Worth The Cost?

Forbes

Fri, 06/1/18 - 11:47 am

Thanks to lower-than-expected price, ICER backs Amgen's Aimovig—but only after other meds fail

Fierce Pharma

Fri, 06/1/18 - 11:40 am

With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?

Endpoints

Tue, 05/29/18 - 09:22 pm

Gilead Sciences

Biopharma M&A: You Ain’t Seen Nothing Yet

Barron's

Fri, 05/25/18 - 09:32 am

Gilead Sciences

Up-and-coming Pfizer, AbbVie drugs set to threaten Amgen, Celgene: analyst

Fierce Pharma

Wed, 05/23/18 - 09:54 am

Will Amgen’s migraine win and 5th thumbs-up for Prolia drive enough growth? Nope, says analyst

Fierce Pharma

Tue, 05/22/18 - 06:06 pm

Amgen And Avalere Reports Reveal "Upside Down" Payer Biosimilar Realities

Biosimilar Development

Mon, 05/21/18 - 06:29 pm

drug development

Amgen, AbbVie 'ahead of the crowd' in fighting payers' latest assault on copay coupons

Fierce Pharma

Mon, 05/21/18 - 09:18 am

Migraine prevention drug could be worth $1 to $2 billion over next five years: Wall Street analyst

CNBC

Sat, 05/19/18 - 11:30 am

AstraZeneca drops Amgen-partnered solid tumor drug

Fierce Biotech

Fri, 05/18/18 - 09:37 pm

Amgen’s new migraine drug will cost 30 percent less than Wall Street expected

Stat

Thu, 05/17/18 - 09:48 pm

Amgen's Aimovig won its first-in-class migraine nod. Will payers step up to the $6,900 price?

Fierce Pharma

Thu, 05/17/18 - 09:42 pm

Pfizer’s Epoetin Alfa Biosimilar Approved by FDA

RAPS.org

Tue, 05/15/18 - 09:14 pm

Are These Disappointing Drugs Back on Track to Billions?

Motley Fool

Sun, 05/6/18 - 01:33 pm

PCSK9 inhibitors

Pages